Home › Funds › Two Sigma Investments › CRSP
Two Sigma Investments position in CRSP
CRISPR THERAPEUTICS AG · Health Care
Latest position (Q2 2026)1.99M sh
Reported value held$108.46M
Portfolio Weight0.08%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 5.27K | $590.00K | New |
| Q4 2021 | 212.58K | $16.11M | Add |
| Q1 2022 | 318.37K | $19.98M | Add |
| Q2 2022 | 45.42K | $2.76M | Reduce |
| Q3 2022 | 112.09K | $7.33M | Add |
| Q4 2022 | 41.73K | $1.70M | Reduce |
| Q1 2023 | 216.03K | $9.77M | Add |
| Q2 2023 | 433.07K | $24.31M | Add |
| Q3 2023 | 219.79K | $9.98M | Reduce |
| Q4 2023 | 85.03K | $5.32M | Reduce |
| Q1 2024 | 49.06K | $3.34M | Reduce |
| Q2 2024 | 17.06K | $921.36K | Reduce |
| Q3 2024 | 179.05K | $8.41M | Add |
| Q4 2024 | 306.27K | $12.05M | Add |
| Q1 2025 | 1.19M | $40.47M | Add |
| Q1 2025 | 1.19M | $40.47M | Add |
| Q2 2025 | 1.55M | $75.20M | Add |
| Q2 2025 | 1.55M | $75.20M | Add |
| Q3 2025 | 1.04M | $67.71M | Reduce |
| Q4 2025 | 470.62K | $24.68M | Reduce |
| Q1 2026 | 1.48M | $70.55M | Add |
| Q2 2026 | 1.99M | $108.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CRSP
- ARK Invest 9.46M sh · $516.00M · Q2 2026
- BlackRock Inc 8.35M sh · $455.35M · Q2 2026
- Capital World Investors 4.75M sh · $259.04M · Q2 2026
- Geode Capital Management 2.51M sh · $136.92M · Q2 2026
- Vanguard Group 2.27M sh · $118.95M · Q4 2025
- Fidelity Management & Research (FMR) 1.91M sh · $104.09M · Q2 2026
- Bank of America Corp 1.16M sh · $63.00M · Q2 2026
- Charles Schwab Investment Management 1.06M sh · $57.69M · Q2 2026
- D. E. Shaw & Co 1.01M sh · $54.98M · Q2 2026
- Morgan Stanley 879.95K sh · $47.99M · Q2 2026
- Northern Trust Corp 863.09K sh · $47.07M · Q2 2026